Clarithromycin to prevent new infections in sepsis after pneumonia
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This study tests whether an antibiotic called clarithromycin can help prevent additional infections in people who have sepsis from pneumonia. The goal is to see if it helps you recover faster and avoid complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with community-acquired pneumonia (a lung infection you got outside the hospital).
- You have sepsis (a severe response to infection that can cause organ damage).
- Your lymphocyte count (a type of white blood cell) is below 1000 per cubic millimeter.
- You are not pregnant, and if you are of childbearing age, you agree to use effective birth control during the study and for 7 days after.
- You are not currently taking a macrolide antibiotic (like azithromycin or clarithromycin) for this pneumonia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving an early antibiotic (meropenem) based on a new blood test (PSP) can prevent serious infections (sepsis) in people who come to the emergency department with signs of infection. The goal is to find out if this approach helps them get better faster and avoid more severe illness.
This trial tests a computer tool to help doctors choose the right antibiotic for sepsis early on. It may help improve treatment by providing personalized recommendations based on your condition.
This trial tests whether using a blood test called procalcitonin (PCT) can help doctors decide when to use antibiotics for critically ill patients in the intensive care unit (ICU). It may help reduce unnecessary antibiotics and improve care.
This trial tests a new medication called OPT101 for people hospitalized with pneumonia and sepsis (a severe infection that affects the whole body). The drug may help reduce inflammation and improve oxygen levels. The study focuses on those who need extra oxygen but are not yet on a breathing machine.
This trial studies people with and without sepsis in the ICU to understand why some get very sick from infections. It aims to find better ways to predict who will have complications and guide treatment.
This trial compares two ways of giving a strong antibiotic (meropenem) to ICU patients with pneumonia and sepsis. It aims to see if giving the drug continuously or in shorter intervals works better. This could help clear the infection faster and improve recovery.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.